fbpx

FORGOT YOUR DETAILS?

CREATE ACCOUNT

  • Home
  • Cannabinoid Clinic

Cannabinoid Clinic

Cannabinoid Clinic

Cannabinoid clinic is an on-line consulting clinic aimed at patients that want to address their endocannabinoid system in order to treat a wide range of diseases and condditions. The clinic is under expert supervision of the International Institute for Cannabinoids ICANNA.

About ICANNA

ICANNA - The International Institute for Cannabinoids is a non-profit NGO, which was formed by the collaboration of partners from Slovenia, Germany and Austria. As an interdisciplinary organization, it brings together an array of experts, researchers and scientists from different countries.

The purpose of the institute is a multi-national cooperation in the field of cannabinoid research. The Institute achieves its goals through the implementation of research, development, analysis, education, training, consulting, monitoring, publishing, informing, raising awareness, proposing expert opinions or standpoints, offering expert advice and similar.

Cannabinoids and medical science

Cannabinoids are a part of official medical science in most of the EU and other western countries for nearly a decade. Most practicing medical doctors however still lack education and support to treat their patients with cannabinoids.

Indications for cannabinoids

Cannabinoids in most developed countries are prescribed to patients as an add-on therapy to improve conventional drug treatment protocols. They are usually also indicated when standard treatment protocols do not offer satisfactory results.

Types of conditions

Cannabinoids treatment consulting, according to a vast body of scientific evidence, could potentially be useful to patients with chronic diseases and serious illnesses. Usually these illnesses are cancer, rheumatoid illnesses, neurological illnesses etc. Increasing number of patients is requesting also preventive counselling related to sleep and mood disorders, seasonal infections etc.

Our services

Consulting focuses on dosing, interaction between cannabinoids and other medications (drug-drug interaction) and indications/counter indications given patients clinical picture.

In providing consulting the Institute collaborates with an international team of medical doctors that specialize in pain prevention, palliative care, neurology, preventive medicine etc.

Preventive consulting

This type of consulting focuses on preventive application of cannabinoids to improve overall health and wellbeing, to address poor sleeping patterns, to improve resistance to stress. Patients in this case do not have a diagnosis of chronic disease or any pharmacological therapy.

Patients provide the Council with written information about their illness or problem (patient self-assessment). The Council shall issue a written opinion and indicative recommendations within one week. It is possible to continue consultations mainly to optimize dosing.

Diagnostic consulting

This service focuses on the use of cannabinoids as an "add-on" therapy in chronic diseases and in the case of concomitant use of drugs. The suitability of cannabinoid use for an existing diagnosis is checked individually based on published studies. In the scientific literature, the expression of cannabinoid receptors on the affected organs or tissues and their specificity (CB1, CB2, TRP receptor family) is checked. Possible interactions with existing drugs are examined and the dosage and route of administration of cannabinoids are advised.

In the extended consulting package, patients provide the council with written information about the diagnosis, including histological findings, indicating medications and their daily doses, and the symptoms that trouble them, despite the therapy introduced. The Council shall issue a written opinion and indicative recommendations within one week.

Patients with more severe medical conditions are treated with priority.

Periodic consulting

If necessary, patients are also provided with periodic consultation and assessment of the condition and, if necessary, optimization of the dosing regimen.

Paediatric patients consulting

Paediatric patients are treated pro bono as part of an expert medical consultation.

Orders and price list

For orders and further information, we are at your disposal at medical.counseling@cebeden.com.

We also offer our services in person by prior arrangement in the Mediwa center in Murska Sobota, Slovenia.

 

Price list:

Preventive consulting – 70 €

Diagnostic consulting – 140 €

Periodic consulting – 70 €

Paediatric patients – pro bono

Council members

Tanja Bagar, Ph.D, Assistant Professor

Tanja Bagar is the CEO and Chairman of the Expert Council of the International Institute for cannabinoids. She is a deputy director in the company that operates in the field of research, development and trade and also the head of research and development in an environmental company. She is active in the academic sphere.

Tanja Bagar is the CEO and Chairman of the Expert Council of the International Institute for cannabinoids. She is a deputy director in the company that operates in the field of research, development and trade and also the head of research and development in an environmental company. She is active in the academic sphere. She lectures microbiology and topics o ecoremediation at the Faculty  Alma Mater Europaea and cooperates scientifically with the Austrian College of Health and Development. She is a member of the Pomurje Academy of Arts and Sciences, Slovenian Biochemical Society, the Slovenian Association of Psychologists and is one of the founders of the society for the preservation and protection of the environment. She has extensive research experience gained in the laboratory at the National Institute of Chemistry, the Faculty of Biotechnology, the National Laboratory for Health, Environment and Food, in the Topolšica Hospital and abroad at the Institute of Microbiology and Genetics at the Georg-August University of Gottingen in Germany and at the Institute for Cell Biology, University of Edinburgh. Since 2013, she participates as a peer reviewer for the national competition of research projects, organized by the Association for Technical Culture of Slovenia. For her social engagement she received a special thanks from the Slovenian Microbiological Society for participation in the promotion of microbiology, a special recognition in a frame of the Slovenian social responsibility award HORUS and an invitation to become a honorary member of the social cooperatives KonopKo.

She attended various conferences on cannabinoids and endocannabinoid system at a national and international level. She holds knowledge in the fields of microbiology, cell biology, biochemistry and molecular biology in conjunction with the endocannabinoid system and the functioning of cannabinoids, laboratory analysis ... She has completed an intensive four week e-education program Concepts of Cannabis Science I, carried out by Kenevir Research (Oregon, USA), and also follow-up program Concepts of Cannabis Science II.

Tanja Bagar was awarded a reward for talented students during her graduate studies of microbiology at the Biotechnical Faculty in Ljubljana and her bachelor thesis received the Preseren-Prize. She continued postgraduate studies at the Faculty of Medicine in Ljubljana, and received a Ph.D. in the field of biomedical sciences. As a young researcher she was awarded the Krka reward for special achievements in the field of research, for the successful completion of the doctoral thesis the municipality golden plaquette. She also completed the professional exam for at the Ministry of health.

Željko Perdija, M.D., Assistant

Željko Perdija is a member of the Governing Board and expert associate of the Institute as well as the CEO and operator of internal medicine at the Internal and Intervention Medicine Centre. He continues to manage the pulmonary departments at health care centres in Lenart and Ormož two days a week.

Željko Perdija is a member of the Governing Board and expert associate of the Institute as well as the CEO and operator of internal medicine at the Internal and Intervention Medicine Centre. He continues to manage the pulmonary departments at health care centres in Lenart and Ormož two days a week. As a provider of medical examinations, he participates in the national program for early colorectal cancer detection, SVIT. He is a member of different medical associations and societies in Slovenia and Europe. He obtained habilitation as an assistant at the Faculty of Medicine in Maribor and gained experience as a lecturer by teaching at the the Medical School in Maribor. He acquired his clinical experience at the University Medical Centre Maribor, University Clinic of Respiratory and Allergic Diseases Golnik, General Hospital Ptuj and with his work for health care institutes. As an internal medicine specialist, he is in everyday contact with patients with his diagnostics work and medical treatments. Several years ago, he began his training in laser medicine and therapeutic use of cannabis.

More and more patients trust him to include cannabinoids in health therapies on his own initiative or in cooperation with experts from countries with more adequate legal regulation. Positive reactions from patients, a growing number of scientific, expert and clinical findings as well as numerous therapeutic possibilities have encouraged his deep interest in this area, above all in CBD. He has completed an intensive four week e-education program Concepts of Cannabis Science I, carried out by Kenevir Research (Oregon, USA), and also follow-up program Concepts of Cannabis Science II.

After graduating from the Faculty of Medicine, Željko Perdija acquired his licence and completed his post-graduate studies on ultrasound use in gastroenterology and hepatology in Zagreb, he specialized in internal medicine, passed all exams at the doctoral study programme at the Faculty of Medicine in Zagreb, a theoretical and practical test in flexible bronchoscopy and additional training at the University Medical Centre Ljubljana on digestive endoscopy.

David Neubauer, M.D., Ph.D., Professor

David Neubauer is a member of the Expert Council and expert associate of the Institute. He is employed in the Pediatric Clinic in Ljubljana in the Clinical department for developmental, child and adolescent neurology, whose representative he was for more than 17 years.

David Neubauer is a member of the Expert Council and expert associate of the Institute. He is employed in the Pediatric Clinic in Ljubljana in the Clinical department for developmental, child and adolescent neurology, whose representative he was for more than 17 years. He has collaborated for over 30 years with the Division of Child Neurology, Childrens' Department, Al-Sabah Hospital in Kuwait, where he is invited as a consultant and a lecturer. As a full professor, he gives lectures at the Faculty of Medicine in Ljubljana and has international experiances as a visiting professor in Kuwait, France, Zambia, Kosovo, Croatia and in Bosnia and Herzegovina. His broad experiences in the field of education include mentorship for the pediatric medical specialists (Medical Chamber of Slovenia), the shaping of the specialization in the field of child neurology, providing lectures for  the program of the doctoral study of Neuroscience at the Faculty of Medicine in Ljubljana, co-chairman of the doctoral program of Neuroscience at the Faculty of Medicine in Zagreb, chairman of the postgraduate study of child and developmental neurology at the Faculty of Medicine in Ljubljana and mentorship for doctoral students of the Faculty of Arts, Faculty of Health Sciences and the Faculty of Sport at the University of Ljubljana, with their doctoral dissertations. His area of expertise lies in the field of neonatal neurology, pediatric neurophysiology, sleeping disturbances and breathing problems during sleep, rare neurodegenerative and neurometabolic diseases and ethics in pediatrics. As a coworker and an operator he collaborated in several national and international researches. He successfully integrated himself into several european projects (RESPECT, nEUroped, SCPE-IV Net, Leonardo da Vinci) and as a lecturer actively took part in the congresses in Slovenia, Croatia, Italy, England, Austria, Germany, Sweden, Kuwait, France, Hungary, Israel, Lebanon, Syria and Turkey. Cooperation in organising several scientific congresses is also one of his active involvements. He has an extensive bibliography and is a longterm executive editor at the library for children neurology and an editor of the Journal of Pediatric Neurology. For almost 20 years now he is the president of the administration for the non-governmental organization Establishment for Children Neurology (Ustanova za otroško nevrologijo) and is a 15 year member of the management in the Association of Slovenian foundations – ZSU. Not only is he the member of those establishments and institutions, but also a member in several other organizations, which operate in the field of health care, like: Slovenian Society for health care – SZD (slovensko zdravniško društvo), European Society for Paediatric Research, Mort Subite Europe Research, European Society for the Study and Prevention of Infant Death, SIDS International, European Pediatric Neurology Society, European Pediatric Sleep Club, European Academy of Childhood Disabilities, International Child Neurology Association, he was the Slovenian representative at the Committee of National Advisors, , Research and Teaching Excellent Students (as the main coordinator) and is the president of the Working group for Ethics at the European Academy of Paediatrics (EAP- Paediatric Section of UEMS).

As a commited pediatrics specialist, he and his colleague Mirjana Perkovič Benedik, M.D., Ph.D., were the first in Slovenia to dedicate themselves to the medical treatment of children, who suffer from refractory epilepsy, with the help of a cannabidiol (CBD) and the medical cannabis sativa. This led him to collaborate at the first observational study of treating children, who suffering from epilepsy in Slovenia, which showed remarkably positive results. Neubauer strives for the upgrade to the previously stated medical treatments, with the implementation of a scientific study in which he would compare the effect of a synthetic CBD and natural CBD – extract, which contains different substances of the cannabis sativa aswell and has even greater potential.  In addition to the effects on epileptic seizures, he is also interested in the impact and effects on behaviour picture of the child, sleeping, motor skills, tics, spasticity etc. He advocates the necessity of doctor education in the field of therapy and treatment with the use of the cannabis sativa, after the necessary arrangements on the legal basis on this matter and taking into account the volition of the people, who have the right to choose for themselves how they want to be treated.

David Neubauer is a doctor of medicine, pediatric specialist, child neurology specialist and a doctor of medical science. Postgraduate education led him to France, England, Zambia, Austria, Kosovo, Denmark and Hungary. He was awarded the title of senior councilor from the minister of health of the republic of Slovenia for his education and active work towards an active contribution to science, pedagogics and research in the field of health care.

For consulting on cannabinoids use with neurlogic paediatric patients please contact dr. Neubauer directly at Paediatric Clinic at University  Medical Centre, Division of Paediatric, Adolescents and Developmental Neurology or on e-mail: david.neubauer@mf.uni-lj.si

Tamara Lah Turnšek, Ph.D., Professor

Tamara Lah Turnšek is a member of ICANNA Institute. In the period from 1995 to 2018, she was the Director of the National Institute of Biology (NIB), where she continues to carry out her research as Programme Leader at the Department of Genetic Toxicology and Cancer Biology, which she established.

Tamara Lah Turnšek is a member of ICANNA Institute. In the period from 1995 to 2018, she was the Director of the National Institute of Biology (NIB), where she continues to carry out her research as Programme Leader at the Department of Genetic Toxicology and Cancer Biology, which she established. She is also a consultant to the NIB Director. She started her research career at the Jožef Stefan Institute and soon focused on biomedicine and its application in the clinic. She became interested in this field already during her specialization in clinical biochemistry at the Paediatric Clinic in Ljubljana, and later, when she worked closely with the Clinic of Stomatology, the Institute of Oncology and the Clinic of Neurosurgery University Medical Clinics in Ljubljana. In the meantime, she was a post-doctor and later an Assistant Professor at the Department of Pharmacology at the Wayne State University, Medical School in Detroit and a visiting Professor and Head of Metastasis Research Department at the Albert Einstein Medical Center in Philadelphia, Pennsylvania, dedicating her entire research to cancer. She is professionally interested in the biology of tumours, and has recently been focusing in stem cells in cancer. The latter could be implemented in clinic, especially in the development and targeting of tumor biomarkers. On this issue she cooperated with pharmaceutical firms in Europe and the USA. She is a member of several international associations and lectures at congresses in different countries, along with her colleagues she has also organized several international meetings for example, a series of Conferences on Experimental and Translational Oncology – CETO since 2004. Due to the topicality of its field, her research program group collaborates with several international research in Europe and beyond.
Tamara Lah Turnšek has until recently acted as the President of the Science and Technology Council, which is the expert consulting body of the Government of the Republic of Slovenia. Her experiences as a member of the EU Helsinki Group for Women in Science also focused on the initiative to set up “National Committee for Promoting Equal Opportunities for Women in Science", which she chaired for several years. She is a full Professor at the Biotechnical Faculty and Faculty of Chemistry and Chemical Technology, University of Ljubljana, was member of the Advisory Body at the Slovenian Academy of Sciences and Arts (SAZU) on ethics in science, and was in the period 2014-2019 chairing the Committee for National Prize for Science Awards, entitled Zois and Puh's Awards. Since 2016 she is also the member of Academy of Engineering of Slovenia (IAS).

Tamara Lah Turnšek is currently also investigating the effectiveness of cannabinoids preparations for treatment of cancer, developing a platform for the individualized treatment of glioblastomas with natural substances, including hemp. She is emphasizing that various obstacles to research in this field need to be eliminated and would encourage all incentives to carry out pre-clinical and clinical research on medical cannabis. She is supporting the initiatives for regulation of the access to cannabis, i.e. its preparations for medical purposes. In this context, she stresses the importance of educating doctors, professionals, students and of course the public on recent scientific endeavours in the field.

Tamara Lah Turnšek graduated from the Faculty of Natural Sciences and Technology of the University of Ljubljana, followed by obtaining her master's degree and PhD in biochemistry from the Faculty of Chemistry and Chemical Technology of the University of Ljubljana.

Erhan Yarar, Ph.D., Emeritus Dr.

Erhan Yarar is a translational medicine expert with 20 years of experience in matters of pediatric and adult oncology, endocrinology and lately in psychiatry. Graduated from Hacettepe University/Turkey and received several certificates from University of Harvard School of Medicine/USA.

Erhan Yarar is a translational medicine expert with 20 years of experience in matters of pediatric and adult oncology, endocrinology and lately in psychiatry. Graduated from Hacettepe University/Turkey and received several certificates from University of Harvard School of Medicine/USA. He had several medical collaborations in treating patients in diverse parts of the world such as USA, Japan, Israel, Germany, Turkey, Cyprus. He applies alternative and complementary medicine along with conventional medicine. He is an emeritus member of International Cannabis Research Society and ICANNA. He has experience in applying CBD,THC, CBG and terpenes to his patients.

Affiliation: Honorary president of the Epigenetics and Nutrigenetics Society, Turkey; Emeritus member of The International Cannabinoid Research Society ICRS, Winston-Salem, NC, USA; Honorary member and editor of The International Journal of Clinical and Medical case reports; Emeritus member of The ICANNA institute; Honorary editor and member of The Open Access Journal of Biogeneric Science and Research.

Certifications: Harvard University of Medicine CME

Latest manuscripts of the year 2020: Epigenetical and Immunological Aspects of Covid-19 (International Journal of Clinical Studies & Medical Case Reports, June 2020); Epigenetical aspect of exogeneous substances and their impact on depression with respect to brain derived neuropathic factor (Journal of Psychiatry and Behavioral Sciences; June 2020) Cannabidiol’s impact on depression (International Journal of Clinical Studies & Medical Case Reports, June 2020); Depression and cannabinoids; ICANNA, June 2020

Recent Posts

Categories

Naložbo VAVČER ZA DIGITALNI MARKETING (izdelavo spletne trgovine) sofinancirata Republika Slovenija in Evropska unija iz Evropskega sklada za regionalni razvoj«

Copyright © 2020 Cebeden. All rights reserved.

TOP